Xuejuan Li
Shenzhen, 518038, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Advances in PD-1 monoclonal antibody therapy for hemophagocytic syndrome.
Journal: Critical reviews in oncology/hematology
Published: June 01, 2026
Neonatal hypoxic-ischemic encephalopathy online registry in Shenzhen: protocol for a multicentre, prospective, open, observational cohort study.
Journal: BMJ open
Published: March 20, 2026
Development and Validation of a Rapid Benefit-Risk Assessment Index for Pediatric Off-Label Drug Use.
Journal: Journal of evidence-based medicine
Published: January 23, 2026
Comparison of the time to detection (TTD) of different blood culture systems and antibiotic adsorption capacity of different pediatric blood culture bottles of BD and bioMérieux.
Journal: Microbiology spectrum
Published: November 21, 2025
Efficacy and Safety of Clobazam Adjunctive Therapy in Pediatric Patients with Drug-Resistant Epilepsy.
Journal: Drug design, development and therapy
Published: August 14, 2025
Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition).
Journal: Translational pediatrics
Published: August 04, 2025
A Population Pharmacokinetics Model of Busulfan in Pediatric Patients with Thalassemia Major.
Journal: Current drug metabolism
Published: May 08, 2025
Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEGasparaginase hypersensitivity.
Journal: Haematologica
Published: May 07, 2025
Clinical Pharmacist Involved in the Treatment of Pneumocystis carinii Pneumonia: A Case Report.
Journal: Infection and drug resistance
Published: July 07, 2024
A retrospective analysis of spontaneous reports of suspected adverse drug reactions to triptorelin acetate in a tertiary pediatric medical center: still a lot of preventable harm.
Journal: BMC pediatrics
Published: May 08, 2024
Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 17, 2024
Cyclohexene oxide CA, a derivative of zeylenone, exhibits anti-cancer activity in glioblastoma by inducing G0/G1 phase arrest through interference with EZH2.
Journal: Frontiers in pharmacology
Published: October 23, 2023
Last Updated: 09/26/2026